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The association between baseline quadriceps strength and worsening of
WOMAC function score








Men 274 (6.5) High (Referent)
277 (5.5) Middle 0.69 (0.32, 1.46) 0.3145
277 (6.1) Low 0.68 (0.34, 1.42) 0.3241
Women 437 (4.4) High (Referent)
432 (4.2) Middle 0.97 (0.49, 1.92) 0.9308
425 (6.4) Low 1.58 (0.82, 3.03) 0.1685
Conclusions: Quadriceps weakness was not associated with an increased
risk for worsening of knee pain severity or worsening self-reported
physical function over 30 months in either men or women. For the goals
of minimizing risk for impairments and functional limitations, these
data do not appear to support the importance of maintaining adequate
quadriceps strength in men and women with or at increased risk for
knee OA.
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Background: Osteoarthritis (OA), a common, minimally inﬂammatory
rheumatological syndrome characterized by chronic joint pain and
dysfunction, the primary symptom of OA is pain that is seen as entirely
linked with function, with physical movements triggering pain, while
pain, in turn, causes limitations in physical function. Chronic pain has
been associated with augmented circulating catecholamines (CAs) and
bradykinin. The presence of natural antibodies (NA) regarding speciﬁcity
and have gained increasing attention in proteome analysis for developing,
monitoring and effective treatment of OA.
Objectives: The objective of the study was to test of natural antibodies
against serum proteins relevant to pain (dopamine DA, adrenaline AD,
noradrenaline NA, bradykinin BK) expression on chronic osteoarthritis
pain.
Methods: We evaluated 75 individuals with chronic pain (>3 months)
due to OA. Pain was moderate to severe (>4 of 10), as self-assessed with
Likert scale (0 to 10) using a daily pain diary for 2 wk before outpatient
screening assessment. The clinical diagnosis of OA was further conﬁrmed
using Kellgren and Lawrence radiographic scoring criteria. 75 healthy
individuals without OA or other pain syndromes, of similar age and
body mass index (BMI), were evaluated as control subjects Table 1. We
compared circulating concentrations of NA against CAs, BK in the using
express ELISA protocol (INR).
Results: We detected signiﬁcantly higher concentrations of DA-IgG and
BK-IgG in OA patients compared with healthy control. In addition, we
found signiﬁcant relationships between serum DA-IgG and BK-IgG in
patients with chronic, moderate to severe OA pain. Elevated DA-IgG
was signiﬁcantly correlated with BK-IgG (r = 0.91; P < 0.005) and VAS
(r = 0.75; P < 0.001) in OA patients. There were no statistically signiﬁcant
differences in mea values for NA to AD and NA in OA patients, compared
with healthy control subjects.
Conclusions: Evaluated together DA-IgG and BK-IgG, they can give
important information about immune system functioning, especially
relating to pain and vascular homeostasis. High throughput technology
has made major contributions to the study autoantigen-antibody systems
as serological markers of pain in OA. Quick and easy to perform ELISA test
for detect DA-IgG/BK-IgG can be routinely used in clinical laboratories.
Our results have potential applications for controlling unwanted pain
and future response to therapy in OA patients.
Table 1. Baseline characteristics
Age (yr) 54±8.8 51±11.1
BMI (kg/m2) 26±2.5 26±3.3
Duration of OA (yr) 13.0±9.8
Pain (visual analog) scores 5.46±2.15 0.00±0.00
Beck Depression Index 5.56±5.69 1.00±1.86
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Purpose: Osteopontin (OPN) is an O-glycosylated phosphoprotein which
is synthesized in a variety of tissues and cells including chondrocytes and
synoviocytes. Accumulating data indicated that OPN is involved in the
process of inﬂammation, immunity, and bone metabolism. OPN knockout
mice have already been created and shown that cartilage degradation
is accelerated in the absence of OPN. Human studies revealed that OPN
protein level increased in the synovial ﬂuid from the patients suffering
from OA and RA. These data strongly suggest that OPN is involved in joint
homeostasis and in the pathogenesis of arthritis. However, the molecular
functions of OPN in these processes are not yet extensively studied. Here
we report that synovial ﬂuid OPN level is associated with the severity of
joint pain.
Methods: This study was approved by the Ethics Committee of
this institute. All patients included in this study gave their full,
written, informed consent for participation prior to the operative
procedure. Tissue samples (synovial ﬂuid and synovial membrane)
were obtained from the patients who underwent anterior cruciate
ligament reconstruction (ACL-R) or total knee arthroplasty (TKA) from
January 2009 till October 2010 in our hospital (OA: 27 samples,
female: 22 male: 5, range 51–90 year-old, average 77 year-old, ACL-R: 17
samples, female: 4 male: 13, range 18–47 year-old, average 27 year-old).
OPN mRNA expressed in synovial membrane was quantiﬁed by RT-QPCR
(Roche, Light Cycler 480, Germany). Total OPN protein levels in synovial
ﬂuid were quantiﬁed using OPN/OPN N-half ELISA kit (IBL, Japan) and
compared them with clinical parameters such as Lysholm score (ACL-R),
visual analogue scale (VAS, TKA), serum C-reactive protein (CRP) level,
and macroscopic observation of cartilage degradation.
Results and Discussion: As previously reported, OPN mRNA expression
level in synovial membrane and OPN protein level in synovial ﬂuid were
signiﬁcantly increased in OA if compared with those of ACL-R.
In the ACL-R group, OPN protein level in synovial ﬂuid was gradually
decreased after the injury. We found that OPN protein level in
synovial ﬂuid was POSITIVELY associated with the severity of joint
pain (Lysholm Score) although it was not statistically signiﬁcant. Since
OPN acts as a pro-inﬂammatory cytokines by enhancing migration,
survival, phagocytosis, and pro-inﬂammatory cytokine production of
macrophages, we hypothesized that OPN induces joint pain by promoting
inﬂammation in the joint. To test this hypothesis, we investigated the
correlation of OPN protein level in synovial ﬂuid with serum CRP level.
However, we did not observe any correlation between these two. Further
analysis is required to elucidate if our hypothesis is correct or not.
Since accelerated degradation of articular cartilage is observed in OPN
knockout mice, we next investigated the correlation of OPN protein
level in synovial ﬂuid with the macroscopic observation of cartilage
degradation. However, we also did not observe any correlation between
these two parameters.
In the TKA group, most interestingly, OPN protein level in synovial ﬂuid
was NEGATIVELY correlated with the severity of joint pain (VAS) in
OA patients (R = −0.469) but not with the serum CRP level by Pearson
product-moment correlation coefﬁcient analysis. These data represent
stark contrast to those of ACL-R group, and further analyses is required
to elucidate the roles of OPN in the regulation of knee joint pain.
Conclusions: Osteopontin level in synovial ﬂuid was associated with the
severity of joint pain. In the ACL-R group, it is POSITIVELY associated
with the severity of joint pain, however, NEGATIVELY correlated in the
TKA group.
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Purpose: Joint symptoms do not correlate perfectly with structural
damage in osteoarthritis (OA), and it is known that psychosocial issues,
